With apologies to stock car racing fans that look at the name and muse about the similarity to “Daytona,” there is nothing fast about this drug save for the speed at which prospective plaintiffs may now flock to their Daytrana attorney.
What is Daytrana, anyway? Daytrana (methylphenidate) is a pharmaceutical manufactured by Noven Pharmaceutical Inc. and used to treat attention deficit hyperactivity disorder (ADHD). The methylphenidate is delivered by way of a transdermal patch worn on the skin.
The problem, as outlined by the US Food and Drug Administration (FDA) last month, is that the Daytrana skin patch could foster permanent loss of skin color involving the skin on which the transdermal patch is affixed or beyond.
The agency reported that between April 2006 through December 2014 there were 51 cases of chemical leukoderma reported. That’s the medical term for skin disfigurement through discoloration fostered through repeated exposure to certain chemicals. While the condition is not dangerous, according to the FDA, the disfigurement is nonetheless unfortunate and is likely irreversible.
What’s more, the Daytrana skin color loss could affect an area much larger than the diameter of the actual patch - up to eight inches in diameter, according to reports received by the FDA.
According to the FDA, the skin discoloration was noted anywhere from two months to four years following commencement of using the Daytrana transdermal system. All 51 patients reporting to the FDA’s Adverse Event Reporting System (AERS) noted a decrease and/or a total loss of skin color. All 51 reports noted the discoloration did not reverse, and skin color was not restored when the medication was stopped. It appears as if the leukoderma fostered a permanent change to skin pigmentation.
While Daytrana is usually applied to an area of the hip, some patients have reported that changes to skin pigmentation and loss of skin color have occurred in areas other than those directly affected by the Daytrana transdermal patch.
READ MORE DAYTRANA PATCH LEGAL NEWS
Plaintiffs will claim had they known about the potential Daytrana side effects and Daytrana skin color loss, they would have chosen an alternative to Daytrana for their child - or themselves.
We will be watching this portfolio as it develops…